Product catalog antigen listed by alphabetic starting with H
| Items 201 to 300 of 921 total | 10 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00003070-P01-25 | HELLS antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009931-Q01-10 | HELZ antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009931-Q01-25 | HELZ antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| HO15-R-25 | Heme Oxygenase-1 (HO-1) antigen | ||||||
| Rat | Purified | >95% | E. coli | 25 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| HO25-R-25 | Heme Oxygenase-1 (HO-1) antigen | ||||||
| Human | Purified | >95% | E. coli | 25 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| H00051409-P01-10 | HEMK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051409-P01-25 | HEMK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA096 | Hemofiltrate CC Chemokine 4 (HCC-4) (LEC) (NCC-4) antigen | ||||||
| Human | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA096X | Hemofiltrate CC Chemokine 4 (HCC-4) (LEC) (NCC-4) antigen | ||||||
| Human | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| AR00068PU-N | Hemoglobin antigen | ||||||
| Human | Purified | Erythrocytes | 2 g / US$ 325 | ||||
| Acris Antibodies GmbH | |||||||
| AR00069PU-N | Hemoglobin A1c antigen | ||||||
| Human | Purified | Erythrocytes | 1 mg / US$ 455 | ||||
| Acris Antibodies GmbH | |||||||
| P180-2 | Hemopexin antigen | ||||||
| Human | Purified | >40% | Plasma | 1 mg / ask | |||
| Scipac Ltd. | |||||||
| PA1334 | Hemopexin-like domain of MMP-2 (C-terminal) (445-635 a.a.) antigen | ||||||
| Human | Purified | >95% | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1334X | Hemopexin-like domain of MMP-2 (C-terminal) (445-635 a.a.) antigen | ||||||
| Human | Purified | >95% | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1334XC | Hemopexin-like domain of MMP-2 (C-terminal) (445-635 a.a.) antigen | ||||||
| Human | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| H00001755-Q01-10 | Hensin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001755-Q01-25 | Hensin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA525 | Heparin Binding EGF-like growth factor (HB-EGF) antigen | ||||||
| Human | >95% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA525X | Heparin Binding EGF-like growth factor (HB-EGF) antigen | ||||||
| Human | >95% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| BIN134 | Hepatitis A Virus (HAV) P2C, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN135 | Hepatitis A Virus (HAV) P2C-P3A, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN136 | Hepatitis A Virus (HAV) P3C, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN087 | Hepatitis A Virus (HAV) Strain pHM175 antigen | ||||||
| Purified | - | FRhK cells | 1 ml / US$ 305 | ||||
| Acris Antibodies GmbH | |||||||
| BIN137 | Hepatitis A Virus (HAV) VP1, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN138 | Hepatitis A Virus (HAV) VP1-P2A, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN139 | Hepatitis A Virus (HAV) VP3, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN140 | Hepatitis A Virus (HAV) VP4-VP2, Recombinant antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN141 | Hepatitis B 'e' Antigen (HBeAg) | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| PA1300 | Hepatitis B 'e' Antigen (HBeAg) | ||||||
| Human | Purified | >95% | E. coli | 0.1 mg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA1300X | Hepatitis B 'e' Antigen (HBeAg) | ||||||
| Human | Purified | >95% | E. coli | 0.5 mg / US$ 555 | |||
| Acris Antibodies GmbH | |||||||
| PA1300XC | Hepatitis B 'e' Antigen (HBeAg) | ||||||
| Human | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| BIN049 | Hepatitis B 'e' Antigen (HBeAg) (160 a.a.) 17kDa | ||||||
| Purified | - | E. coli | 0.1 mg / US$ 685 | ||||
| Acris Antibodies GmbH | |||||||
| VTI-610 | Hepatitis B Core Antigen (HBcAg) | ||||||
| Purified | - | Pichia pastoris | 0.1 mg / ask | ||||
| Vybion Inc. | |||||||
| VTI-610X | Hepatitis B Core Antigen (HBcAg) | ||||||
| Purified | - | Pichia pastoris | 1 mg / ask | ||||
| Vybion Inc. | |||||||
| BIN048 | Hepatitis B Core Antigen (HBcAg) (180 aa) 2500kDa | ||||||
| Purified | - | E. coli | 0.1 mg / US$ 685 | ||||
| Acris Antibodies GmbH | |||||||
| BIN024 | Hepatitis B Core Antigen (HBcAg) (183 aa) | ||||||
| Purified | - | Pichia pastoris | 0.1 mg / US$ 585 | ||||
| Acris Antibodies GmbH | |||||||
| BIN069 | Hepatitis B Core Antigen (HBcAg) (ayw) (1-144) 14kDa | ||||||
| Purified | - | E. coli | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN077 | Hepatitis B Core Antigen (HBcAg) (ayw) (1-183) 18kDa | ||||||
| Purified | - | E. coli | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN047 | Hepatitis B pre-S1 Antigen (108 aa) 13.5 kDa | ||||||
| Purified | - | E. coli | 0.1 mg / US$ 685 | ||||
| Acris Antibodies GmbH | |||||||
| BIN142 | Hepatitis B Surface Antigen (HBsAg) (ad) | ||||||
| Human | Purified | - | Plasma | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| BIN063 | Hepatitis B Surface Antigen (HBsAg) (adw) | ||||||
| Purified | - | S. cerevisiae | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN143 | Hepatitis B Surface Antigen (HBsAg) (ay) | ||||||
| Human | Purified | - | Plasma | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| BIN061 | Hepatitis B Surface Antigen (HBsAg) (ayw) | ||||||
| Purified | - | S. cerevisiae | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN144 | Hepatitis B Surface Antigen (HBsAg) (ayw) Recombinant | ||||||
| Purified | - | Pichia pastoris | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN093 | Hepatitis B Surface Antigen (HBsAg), adr subtype | ||||||
| Purified | >98% | S. cerevisiae | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| PA509X | Hepatitis B Virus Protein X (HBx) antigen | ||||||
| Human | Purified | >95% | E. coli | 0.1 mg / US$ 565 | |||
| Acris Antibodies GmbH | |||||||
| GTX22580 | Hepatitis B Virus Surface Antigen (Ayw) (S Region) protein | ||||||
| 100 µg / --- | |||||||
| GeneTex Inc. | |||||||
| VTI-710D | Hepatitis C nucleocapsid Antigen (HCV) | ||||||
| Purified | - | Pichia pastoris | 0.1 mg / ask | ||||
| Vybion Inc. | |||||||
| VTI-710DX | Hepatitis C nucleocapsid Antigen (HCV) | ||||||
| Purified | - | Pichia pastoris | 1 mg / ask | ||||
| Vybion Inc. | |||||||
| VTI-710ND | Hepatitis C nucleocapsid Antigen (HCV) | ||||||
| Purified | - | Pichia pastoris | 0.1 mg / ask | ||||
| Vybion Inc. | |||||||
| VTI-710NDX | Hepatitis C nucleocapsid Antigen (HCV) | ||||||
| Purified | - | Pichia pastoris | 1 mg / ask | ||||
| Vybion Inc. | |||||||
| BIN149 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 1 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN150 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 2 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN145 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 3 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN146 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 4 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN147 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 5 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN148 | Hepatitis C Virus (HCV) Core Ag (a.a. 2-120) genotype 6 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00070PU-N | Hepatitis C Virus (HCV) Core Antigen (1-120) Genotype 1a | ||||||
| Purified | Pichia pastoris | 0.1 mg / US$ 685 | |||||
| Acris Antibodies GmbH | |||||||
| BIN026 | Hepatitis C Virus (HCV) Core Antigen (2-122) 16kDa | ||||||
| Purified | - | Pichia pastoris | 0.1 mg / US$ 585 | ||||
| Acris Antibodies GmbH | |||||||
| BIN078 | Hepatitis C Virus (HCV) Core Antigen (2-192) 22kDa | ||||||
| FITC | - | E. coli | 0.1 mg / US$ 515 | ||||
| Acris Antibodies GmbH | |||||||
| BIN078X | Hepatitis C Virus (HCV) Core Antigen (2-192) 22kDa | ||||||
| Purified | - | E. coli | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN080 | Hepatitis C Virus (HCV) Core Antigen (2-192) 22kDa | ||||||
| Biotin | - | E. coli | 0.1 mg / US$ 515 | ||||
| Acris Antibodies GmbH | |||||||
| BIN076 | Hepatitis C Virus (HCV) NS-3 Antigen (1450-1643) 22kDa | ||||||
| Purified | >95% | E. coli | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN151 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 1a antigen | ||||||
| Purified | - | E. coli | 1 mg / US$ 635 | ||||
| Acris Antibodies GmbH | |||||||
| BIN152 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 1c antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN153 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 2b antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN154 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 2c antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN155 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 5a antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN156 | Hepatitis C Virus (HCV) NS-3 c33c (a.a.1192-1459) Subtype 6a antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00071PU-N | Hepatitis C Virus (HCV) NS-3, C-term, Genotype 1b antigen | ||||||
| Purified | E. coli | 0.1 mg / US$ 515 | |||||
| Acris Antibodies GmbH | |||||||
| AR00072PU-N | Hepatitis C Virus (HCV) NS-4 antigen | ||||||
| Purified | E. coli | 1 mg / ask | |||||
| Acris Antibodies GmbH | |||||||
| BIN157 | Hepatitis C Virus (HCV) NS-4 Antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN079 | Hepatitis C Virus (HCV) NS-4a+b Antigen (1658-1863) 19kDa | ||||||
| Biotin | - | E. coli | 0.1 mg / US$ 515 | ||||
| Acris Antibodies GmbH | |||||||
| BIN079F | Hepatitis C Virus (HCV) NS-4a+b Antigen (1658-1863) 19kDa | ||||||
| FITC | - | E. coli | 0.1 mg / US$ 515 | ||||
| Acris Antibodies GmbH | |||||||
| BIN079X | Hepatitis C Virus (HCV) NS-4a+b Antigen (1658-1863) 19kDa | ||||||
| Purified | - | E. coli | 0.5 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN158 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 1 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN159 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 2 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN164 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 3 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN161 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 4 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN162 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 5 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN163 | Hepatitis C Virus (HCV) NS-5 (a.a. 2212-2313) genotype 6 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN165 | Hepatitis C Virus (HCV) NS-5 (a.a. 2322-2423) genotype 1a antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00073PU-N | Hepatitis C Virus (HCV) NS-5a Genotype 1a antigen | ||||||
| Purified | E. coli | 0.1 mg / US$ 515 | |||||
| Acris Antibodies GmbH | |||||||
| BIN166 | Hepatitis C Virus (HCV) Nucleocapsid NS3/NS4/NS5 antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| AR00074PU-N | Hepatitis D Virus (HDV) antigen | ||||||
| Purified | E. coli | 1 mg / US$ 685 | |||||
| Acris Antibodies GmbH | |||||||
| BIN039 | Hepatitis D Virus (HDV) p24 antigen | ||||||
| Purified | - | S. cerevisiae | 0.1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN168 | Hepatitis E Virus (HEV) ORF2 and ORF3 Antigen | ||||||
| Purified | - | E. coli | 1 mg / ask | ||||
| Acris Antibodies GmbH | |||||||
| BIN097 | Hepatitis E Virus (HEV) ORF2 Antigen (403-461) | ||||||
| Purified | >95% | E. coli | 0.1 mg / US$ 495 | ||||
| Acris Antibodies GmbH | |||||||
| BIN096 | Hepatitis E Virus (HEV) ORF2 Antigen (633-659) | ||||||
| Purified | >95% | E. coli | 0.1 mg / US$ 495 | ||||
| Acris Antibodies GmbH | |||||||
| BIN167 | Hepatitis E Virus (HEV) ORF3 Antigen (92-123) | ||||||
| Purified | - | E. coli | 0.1 mg / US$ 495 | ||||
| Acris Antibodies GmbH | |||||||
| DA3506 | Hepatocyte Growth Factor (HGF) antigen | ||||||
| Human | Purified | >85% | Insect cells | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3506X | Hepatocyte Growth Factor (HGF) antigen | ||||||
| Human | Purified | >85% | Insect cells | 25 µg / US$ 515 | |||
| Acris Antibodies GmbH | |||||||
| PA177 | Hepatocyte Growth Factor (HGF) antigen | ||||||
| Human | >98% | Insect cells | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA177X | Hepatocyte Growth Factor (HGF) antigen | ||||||
| Human | >98% | Insect cells | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| H00009146-Q01-10 | Hepatocyte growth factor-regulated tyrosine kinase substrate antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009146-Q01-25 | Hepatocyte growth factor-regulated tyrosine kinase substrate antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009843-Q01-10 | Hephaestin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009843-Q01-25 | Hephaestin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR03028PU-N | Herbimycin A Inhibitor antigen | ||||||
| Purified | >98% | 1 mg / ask | |||||
| Acris Antibodies GmbH | |||||||
| AR03028PU-S | Herbimycin A Inhibitor antigen | ||||||
| Purified | >98% | 0.1 mg / US$ 365 | |||||
| Acris Antibodies GmbH | |||||||
| H00008916-Q01-10 | HERC3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 201 to 300 of 921 total | 10 Page(s): |
